tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/amivantamabe2026-10-22T15:48:56.207578-03:00anvisa-feedsanvisa-feeds (dados: CMED/ANVISA)tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/amivantamabe/202610092026-10-22T15:48:56.207578-03:00<p>sem mudanças</p><table class="queue" id="rows"><caption>Lista atual (5 apresentações)</caption><thead><tr><th>Produto</th><th>Apresentação</th><th>Laboratório</th><th>PF 0 %</th><th>PMC 0 %</th><th>PMVG 0 %</th><th class="d">Regime</th></tr></thead><tbody><tr title="GGREM 514525080042602"><td>RYBREVANT</td><td>1600 MG SOL INJ CT FA VD TRANS X 10 ML</td><td>JANSSEN-CILAG FARMACEUTICA LTDA</td><td class="p">R$ 27.617,68</td><td class="p">–</td><td class="p">R$ 22.152,14</td><td class="d">Regulado</td></tr><tr title="GGREM 514525080042702"><td>RYBREVANT</td><td>2240 MG SOL INJ CT FA VD TRANS X 14 ML</td><td>JANSSEN-CILAG FARMACEUTICA LTDA</td><td class="p">R$ 38.664,76</td><td class="p">–</td><td class="p">R$ 31.013,00</td><td class="d">Regulado</td></tr><tr title="GGREM 514526080046507"><td>RYBREVANT</td><td>2400 MG SOL INJ CT FA VD TRANS X 15 ML</td><td>JANSSEN-CILAG FARMACEUTICA LTDA</td><td class="p">R$ 48.659,72</td><td class="p">–</td><td class="p">R$ 39.029,96</td><td class="d">Regulado</td></tr><tr title="GGREM 514522020039107"><td>RYBREVANT</td><td>350 MG SOL DIL INFUS CT FA VD TRANS X 7 ML</td><td>JANSSEN-CILAG FARMACEUTICA LTDA</td><td class="p">R$ 9.205,89</td><td class="p">–</td><td class="p">R$ 7.384,04</td><td class="d">Regulado</td></tr><tr title="GGREM 514526080046607"><td>RYBREVANT</td><td>3520 MG SOL INJ CT FA VD TRANS X 22 ML</td><td>JANSSEN-CILAG FARMACEUTICA LTDA</td><td class="p">R$ 71.367,59</td><td class="p">–</td><td class="p">R$ 57.243,94</td><td class="d">Regulado</td></tr></tbody></table>